MIT-Takeda Program heads into fourth year with crop of 10 new projects,MIT-Takeda Program heads...
Biopharmaceuticals
Stocks Inch Higher After Indexes Post Worst Week of 2023,A rebound in the shares...
Opinion | The FDA Returns to Its Bad Habits,The agency may nix a new...
